Citations

Citations to this article as recorded by  

• The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
  Malihe Rezaee, Fatemeh Mohammadi, Atoosa Keshavarzmotamed, Sheida Yahyazadeh, Omid Vakili, Yaser Eshaghi Milasi, Vida Veisi, Rohollah Mousavi Dehmordi, Sepideh Asadi, Seyedeh Sara Ghorbanhosseini, Mehdi Rostami, Mina Alimohammadi, Abbas Azadi, Nushin Mous
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Circular RNA circ-MMP11 Contributes to Lapatinib Resistance of Breast Cancer Cells by Regulating the miR-153-3p/ANLN Axis
  Xiaoli Wu, Yi Ren, Rong Yao, Leilei Zhou, Ruihua Fan
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Activated estrogen receptor‐mitogen‐activated protein kinases cross talk confer acquired resistance to lapatinib
  Zhe Li, Sheng‐Sheng Yang, Pei‐Hao Yin, Tao Chang, Lin‐Xiang Shi, Lin Fang, Guo‐En Fang
  Thoracic Cancer.2015; 6(6): 695.     CrossRef
• Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience
  Jae-Cheol Jo, Myoung Joo Kang, Jeong Eun Kim, Jin-Hee Ahn, Kyung Hae Jung, Gyungyub Gong, Hak Hee Kim, Seung Do Ahn, Su Ssan Kim, Byung Ho Son, Sei Hyun Ahn, Sung-Bae Kim
  Cancer Chemotherapy and Pharmacology.2013; 72(1): 201.     CrossRef
• Lapatinib – kezelési lehetőség trastuzumab-rezisztens emlőrákban
  Béla Pikó
  Magyar Onkológia.2009; 53(4): 369.     CrossRef